Get notified of page updates

Search Results: (30 results)

New Search
PRINTER FRIENDLY PAGE 1 through 30 of 388

Surveys, Registries, Interviews
Study of cancer risk linked to Lynch syndrome gene changes

Understanding Cancer Risk in People with Lynch Syndrome (LINEAGE)

An observational study of cancer risk linked to inherited Lynch syndrome gene changes.

Clinicaltrials.gov identifier: NCT06582914

Treatment
Metastatic breast cancer treatment study

Phase 1/2

Evaluating the Benefit of Adding ART6043 to Olaparib for HER2-Negative Metastatic or Advanced Breast Cancer and a BRCA Mutation (POLKA)

This study is evaluating the addition of ART6043, a novel targeted therapy, to olaparib, a standard treatment, in adults with HER2-negative advanced or metastatic breast cancer and an inherited BRCA mutation.

Clinicaltrials.gov identifier: NCT05898399

Treatment
Study for advanced solid tumors with specific KRAS or other RAS mutations

Phase 1/2

Treating Advanced Solid Tumors with Specific RAS Mutations

Phase 1/2 treatment trial enrolling adults with advanced solid tumors, including pancreatic, colorectal, and non-small cell lung cancers, with specific KRAS or other RAS mutations. A pancreatic cancer expansion group may also include tumors without a RAS mutation.

Clinicaltrials.gov identifier: NCT05379985
Your saliva can help fight cancer!
VIRTUAL

Surveys, Registries, Interviews
A registry for anyone aged 18 and older who lives in the United States

Research Study on the Genetics of Breast Cancer

We are conducting a fully-online research study to learn more about how genes affect your risk of breast cancer. No office visit is required. Participants provide consent online, answer questions online about their health and medical history, and provide DNA via a saliva sample using a pre-paid mailer through the mail. In return for participation, study participants may receive information about their genetic ancestry for free.

Clinicaltrials.gov identifier: NCT06773897

Treatment
Study for metastatic castration-resistant prostate cancer with an HRR mutation

Phase 2

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone or Darolutamide (TALENT)

This study compares talazoparib with or without Enzalutamide in patients with metastatic castration-resistant prostate cancer and an HRR mutation after progression on Abiraterone Acetate or Darolutamide

Clinicaltrials.gov identifier: NCT06844383
VIRTUAL

Quality of Life
Pilot of app and feedback survey for previvors

PreCharge: Study Testing a Digital Program for People with Hereditary Cancer Syndromes

The PreCharge study is testing a digital program featuring online activities and text messages for people with hereditary cancer syndromes who have not been diagnosed with cancer.

Clinicaltrials.gov identifier: NCT07936682

Treatment
Study of hormone and targeted therapy for advanced breast cancer

Phase 1/2

ERADICATE: Hormone and Targeted Therapy for HR+/HER2-Low Advanced Breast Cancer

The study is for people with hormone receptor-positive (HR+), HER2-low or HER2-ultralow breast cancer that has spread to other parts of the body (metastatic) or is locally advanced and cannot be removed with surgery.

Clinicaltrials.gov identifier: NCT07198724

Prevention
Prevention study for postmenopausal women at increased risk for breast cancer

Phase 2

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

This study compares low-dose tamoxifen alone with low-dose tamoxifen plus omega-3 fatty acids in postmenopausal women who are overweight or obese and at increased risk for breast cancer.

Clinicaltrials.gov identifier: NCT06195306
VIRTUAL

Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested

Phase 3

IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer

The IGNITE-TX study is all about helping people with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome talk to their family members about their risk for cancer and find the best way to get family members tested.

Clinicaltrials.gov identifier: NCT07318363
VIRTUAL

Surveys, Registries, Interviews
Survey of prostate cancer awareness, care experiences, and unmet needs

The ZERO Prostate Cancer BEACON (Barriers, Education, Awareness, Care, Outcomes, and Needs) Survey

BEACON is designed to build a comprehensive understanding of the state of prostate cancer awareness and care from the perspectives of men at risk, patient/survivors, caregivers, and healthcare professionals 21 and older.

VIRTUAL

Surveys, Registries, Interviews
Registry for anyone diagnosed with breast cancer

ShareForCures®: Komen's People-Powered, Data-Driven Breast Cancer Research Registry

Today, researchers are learning about breast cancer from a small subset of patients, who are not representative of all breast cancer patients. ShareForCures® is an online registry that offers people who have been diagnosed with breast cancer a way to participate in research by connecting information about themselves with their breast cancer diagnosis, medical records, genomics. Participation is open to anyone adult, living in the United States, and who has been diagnosed with breast cancer.

Clinicaltrials.gov identifier: NCT05654246
VIRTUAL

Surveys, Registries, Interviews
Survey and interview for hereditary breast cancer patients in therapy

Share Your Experience with Psychotherapy After a Hereditary Breast Cancer Diagnosis

This study aims to understand the lived experiences of people with hereditary breast cancer who have had psychotherapy after receiving their genetic diagnosis.

Quality of Life
Study evaluating a mobile app for depression in adults with likely incurable cancer and elevated depressive symptoms

IMPACT: Improving Proactive Approaches for Cancer Survivors’ Mental Health Treatment

This study is evaluating whether a mobile app called Moodivate can help improve depressive symptoms in adults living with likely incurable cancer.

Clinicaltrials.gov identifier: NCT06582784
VIRTUAL

Surveys, Registries, Interviews
Survey of caregivers of women with breast cancer diagnosed before 45

Survey for Caregivers or Supporters of Women Diagnosed With Breast Cancer Before Age 45

This study explores the experiences of people who support a woman diagnosed with breast cancer before age 45

Prevention
Colon cancer screening study for people with Lynch syndrome

FIT Testing for Colorectal Cancer Screening in People with Lynch Syndrome

People with Lynch syndrome currently rely on regular colonoscopies to screen for colorectal cancer. Researchers are studying whether a simple stool-based test called the fecal immunochemical test (FIT) can help identify people who may need a colonoscopy while reducing the burden of frequent screening. This study will compare FIT results with colonoscopy findings in people with Lynch syndrome.

Clinicaltrials.gov identifier: NCT06898996

Prevention
Prevention study for people with a history of early-stage melanoma and at least three atypical moles

Phase 2

Broccoli Sprout Extract for Melanoma Prevention in People With a History of Melanoma and Atypical Moles

Study of a broccoli sprout extract in people with a history of melanoma and multiple atypical moles.

Clinicaltrials.gov identifier: NCT07040280

Surveys, Registries, Interviews
Observational study for people with a CTNNA1 mutation or their first-degree relatives

CTNNA1 Familial Expansion Study (CAFÉ)

The CAFÉ Study is investigating how changes in the CTNNA1 gene may be associated with hereditary cancers, including stomach and breast cancer.

Clinicaltrials.gov identifier: NCT05126290
VIRTUAL

Quality of Life
Exercise study for people diagnosed within the past 5 years

Virtual Exercise Classes for Adult Cancer Survivors (SURGE)

This study compares live, online group exercise classes with recorded exercise videos to see how they affect physical activity, physical fitness, quality of life, and loneliness among cancer survivors.

Clinicaltrials.gov identifier: NCT07290309

Treatment
Treatment study for people with metastatic breast cancer

Using a Computer Model to Identify Treatment Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Researchers want to know if a computer program can help choose FDA-approved drugs that will treat advanced breast cancer more effectively. 

 

Clinicaltrials.gov identifier: NCT07067138
VIRTUAL

Surveys, Registries, Interviews
Interview for eligible previvors

Previvors’ Perceptions of Preimplantation Genetic Testing (PGT-M) After a Cancer Predisposition Diagnosis

This study is designed to learn previvors’ perceptions of their reproductive options and measure their awareness of PGT-M.

Treatment
Treatment study for people with advanced or metastatic cancers

Phase 1

Treating Advanced MSI-High or dMMR Cancers Using the Targeted Therapy MOMA-341 Given Alone or In Combination with Standard Therapies

This trial will study the safety, tolerability, and initial effectiveness of MOMA-341, a new type of targeted therapy, alone or in combination with a standard chemotherapy (irinotecan) or together with an immunotherapy to treat people with advanced or metastatic cancers with certain types of mutations.

Clinicaltrials.gov identifier: NCT06974110
VIRTUAL

Surveys, Registries, Interviews
Survey for men with a BRCA1 or BRCA2 genetic mutation

Beyond a "Women's Gene": Assessing the Perception and Satisfaction Following Genetic Counseling for Males with a BRCA Mutation

Survey to better understand the experiences of men who tested positive for a BRCA1 or BRCA2 genetic mutation. 

Prevention
Family communication study after colorectal cancer diagnosis

Family Communication After Genetic Testing for Colorectal Cancer

This study is looking at genetic testing in newly-diagnosed colorectal cancer patients and comparing different ways of helping family members learn about their potential inherited cancer risk and access genetic testing.

Clinicaltrials.gov identifier: NCT07143487
Text reading "Survey" above a speech bubble and bar graph.
VIRTUAL

Surveys, Registries, Interviews
Online survey on stomach cancer risk for people with an inherited mutation in genes that are linked to an increased risk of cancer

Understanding Risk Factors for Stomach Cancer in People with Inherited Mutations

The purpose of this study is to understand gastric (stomach) cancer risk among people with an inherited (germline) mutation in genes that are linked to an increased risk of certain cancers, including APC, ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM), MUTYH, STK11, and other genes linked to increased cancer risk. 


Study for relapsed platinum-sensitive ovarian cancer

Phase 1/2

Testing COM701 Maintenance Treatment to Delay Cancer Growth After Platinum Chemotherapy for Ovarian Cancer That Has Come Back

This study tests whether COM701 (an anti‑PVRIG immunotherapy) given every 3 weeks as maintenance can delay cancer growth after a good response to platinum chemotherapy. Adults with relapsed platinum‑sensitive ovarian, fallopian tube, or primary peritoneal cancer are randomized 2:1 to COM701 or placebo.

Clinicaltrials.gov identifier: NCT06888921

Quality of Life
Study for those experiencing mental health struggles due to a diagnosis of cancer or other medical illness

Phase 2

REKINDLE: Your Ability to Cope With a Life-Changing Medical Diagnosis

A diagnosis of cancer or other serious medical condition changes everything — including your mental health. Those experiencing negative mental health changes after receiving a diagnosis may be dealing with what is known as Adjustment Disorder.

Clinicaltrials.gov identifier: NCT07002034

Treatment
Treatment study for people with recurrent platinum-resistant ovarian cancer

Phase 1

A New Drug, DT2216, Combined With Paclitaxel for Recurrent Platinum-Resistant Ovarian Cancer

This study is testing a new drug called DT2216 in combination with the chemotherapy drug paclitaxel for people whose ovarian cancer has returned and no longer responds to platinum-based chemotherapy.

Clinicaltrials.gov identifier: NCT06964009

Prevention
A study testing two multi-cancer detection blood tests in people who do not have cancer

Multi-Cancer Detection Blood Tests in Adults Without Cancer: Vanguard Study

The Vanguard Study is looking at how multi-cancer detection (MCD) blood tests could fit into cancer screening.

Clinicaltrials.gov identifier: NCT06995898

Quality of Life
Study for people with metastatic breast cancer and osteoporosis

Phase 2

A Study of the Drug Romosozumab in People With Metastatic Breast Cancer and Osteoporosis

The researchers are doing this study to see if the drug romosozumab is effective at helping with bone formation in people with metastatic breast cancer (MBC) that has spread to the bones. The researchers will also look at bone breakdown (resorption) in participants and determine if romosozumab is a safe treatment for osteoporosis in people with MBC that has spread to the bones.

Clinicaltrials.gov identifier: NCT07776613


Remote clinical trial enrolling adult cancer survivors with cancer-related fatigue and sleep disturbances

Testing an Acupressure App for Cancer Survivors with Fatigue and Sleep Problems

This clinical trial is testing whether using acupressure guided by the EnergyPoints App can reduce cancer-related fatigue and improve sleep in adult cancer survivors residing in the U.S.

Clinicaltrials.gov identifier: NCT06754722

Additional Results on Clinicaltrials.gov
1000 results

Showing the first 1,000 of 2,390 results. Narrow your search to see more specific results.

Clinical Trial Official Title
NCT02749474 Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
NCT05111561 Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
NCT04947254 Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
NCT04666727 Role of Diet on the Microbiome of the Digestive System
NCT07816666 Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07391956 Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
NCT07140172 Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07567027 Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
NCT07226986 A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
NCT00898131 Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
NCT07796061 Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)
NCT07028853 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT06600906 Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
NCT07320664 Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women
NCT06463028 Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
NCT07848828 Autonomic and Renal Contributions to Hypertension With ADT
NCT06675136 Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases
NCT06244004 FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
NCT05753306 Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
NCT04606914 Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT04073706 Sentinel Node Biopsy in Endometrial Cancer
NCT06095089 A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
NCT04594187 Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
NCT06686043 HPV Vaccine, Imiquimod, and Metformin Combination Trial
NCT02000089 The Cancer of the Pancreas Screening-5 CAPS5)Study
NCT04362826 Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer
NCT06353321 Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1
NCT06798558 Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
NCT05797168 Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT06553885 Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
NCT04692675 Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04550845 Understanding of Genetics by Men at Risk for Prostate Cancer
NCT07029399 A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
NCT07307664 Increasing Germline Genetic Testing for Patients With Cancer
NCT05435495 Mechanisms of Resistance to PSMA Radioligand Therapy
NCT07223411 Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
NCT06092892 IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
NCT06149481 Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
NCT04965064 Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling
NCT06910657 IDOV-Immune for Advanced Solid Tumors
NCT06270043 Focal Therapy for Localized Prostate Cancer
NCT05748834 Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
NCT05612347 Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT06085833 ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
NCT07224464 The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
NCT07482384 Supporting Health Including Endocrine Treatment for Long Duration
NCT07332455 First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
NCT07137416 Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
NCT05035836 A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
NCT07549958 PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)
NCT07548164 Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT05595499 Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
NCT07158021 Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
NCT06817226 BREAST Choice Decision Tool R21 - AIM2
NCT03604315 Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
NCT03567889 Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT05979610 Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
NCT06371768 Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
NCT07594015 Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
NCT07845617 Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
NCT07454642 AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
NCT04402151 Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
NCT06252545 Promoting CT Engagement for Pancreatic Cancer With App
NCT06788886 Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
NCT06657222 First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
NCT04923542 SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
NCT07073794 Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
NCT07522073 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
NCT06472661 FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
NCT06444269 Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
NCT06545604 Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
NCT06039085 Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
NCT06582017 Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
NCT01416714 Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
NCT06953089 DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
NCT06534918 Precise Oncology Interventions in Nutrition and Training (OnPoint)
NCT04916990 Improving Care for Rural Patients With Solid Tumors
NCT05677490 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
NCT03866382 Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
NCT05372640 Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
NCT05879913 ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NCT06893276 e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
NCT06529523 Tislelizumab in People With Colorectal Cancer
NCT07644559 A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
NCT05590624 Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer
NCT06349590 Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
NCT07721259 A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden
NCT06922591 Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
NCT05559879 Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
NCT07124351 Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
NCT06398639 Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
NCT06675357 Using FAPI PET/MRI to Evaluate Prostate Cancer
NCT05174286 Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
NCT06202183 Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
NCT03941756 Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
NCT07756281 First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer
NCT07542041 Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
NCT03972657 A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
NCT04923178 A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
NCT07664735 A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
NCT05327608 Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery
NCT06190899 Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
NCT03382158 International PPB/DICER1 Registry
NCT06726148 Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06867484 Breast Re-irradiation After Second Ipsilateral Lumpectomy
NCT07325721 Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
NCT05939414 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
NCT07764133 Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer
NCT06340568 A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT07223385 High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
NCT07733674 Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07391774 Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
NCT07087691 Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance
NCT06576115 Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
NCT07197723 Study of How People Make Decisions About Prostate Cancer Risk
NCT06298734 High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
NCT06083844 Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy
NCT07341503 The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
NCT06062745 Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
NCT05852041 rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
NCT06315595 Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
NCT07339176 Intratumoral N17350 in Advanced Solid Tumors
NCT07629960 A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
NCT07226856 BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
NCT06833866 Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
NCT01530373 Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
NCT05497531 Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
NCT04332588 Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
NCT07382583 Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer
NCT06219941 AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
NCT07174336 A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT06518057 Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
NCT06305312 Community Services Navigation to Advance Health Equity in Breast Cancer Screening
NCT07698314 A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
NCT06887348 A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
NCT06943521 A Study of MT-4561 in Patients With Various Advanced Solid Tumors
NCT07192614 A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
NCT04003038 Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
NCT00034216 Collection of Blood From Patients With Cancer
NCT07224009 Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
NCT06272864 BostonGene and Exigent Genomic INsight Study
NCT07009093 Utility of a Mobile Application for Young Women With Breast Cancer
NCT01050504 Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT07219147 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT07729150 Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
NCT04119024 Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT07364474 Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
NCT06026410 KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
NCT06398418 R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
NCT06835569 A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
NCT06185205 ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
NCT04294927 TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT07910383 The Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease Recurrence
NCT06672497 Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
NCT03474913 Upright MRI for Prostate Cancer Screening
NCT03492424 Ablative Therapy in the Management of Prostate Cancer
NCT07767474 A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors
NCT04796818 An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
NCT06492759 High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
NCT07321106 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
NCT06681233 Feasibility Study of CBCT for IGRT in Cancer Patients
NCT04486352 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
NCT04893109 ATEMPT 2.0: Adjuvant T-DM1 vs TH
NCT04852887 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
NCT05780814 The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
NCT05787834 Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
NCT06103864 A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
NCT07677267 A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan
NCT05691465 Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
NCT06059118 Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
NCT06926868 A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT06696768 Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
NCT05429970 A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
NCT07740941 NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
NCT07899151 Decision Support for Chemoprevention
NCT07718854 Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
NCT03539822 Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
NCT06593431 Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
NCT06330805 Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
NCT05037825 The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
NCT05698576 TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
NCT07011576 A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
NCT02918474 Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
NCT07441889 HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
NCT06945315 SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
NCT07085091 A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NCT07049276 The Multicentre Selective Lymphadenectomy Trial - 3
NCT05766891 Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
NCT04991948 Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
NCT07443943 A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
NCT06534125 Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer
NCT07182149 A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
NCT07221149 A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
NCT05372614 Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
NCT06532006 A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
NCT05178498 Impact of Dietary Inflammatory Potential on Breast Cancer Risk
NCT06290193 Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
NCT03053193 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
NCT06246916 A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
NCT04816006 Breast Cancer, Reasoning, and Activity Intervention
NCT07822399 A Study of MGC030 in Participants With Advanced Solid Tumors
NCT07020806 [68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
NCT07466498 Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
NCT07862582 RYZ711 Diagnostic Platform Study
NCT07723651 [18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
NCT06925724 A Study of Ivonescimab in People With Endometrial and Cervical Cancers
NCT02830724 Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
NCT07335224 Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
NCT04986423 ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
NCT05761561 Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
NCT06049355 EMBRACE: Exercising Together
NCT04899908 Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
NCT05608252 VS-6766+Abema+Fulv in Met HR+/HER- BC
NCT05534438 A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
NCT06524973 Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers
NCT06037954 A Study of Mental Health Care in People With Cancer
NCT05103683 First in Human Study of TORL-1-23 in Participants With Advanced Cancer
NCT04763980 Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
NCT07807345 Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
NCT06863272 A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
NCT07319195 Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
NCT07409272 A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
NCT04693377 Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
NCT04888975 A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
NCT03675893 RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
NCT06555133 Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
NCT07076147 Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
NCT04633252 A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
NCT04520139 Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
NCT05588453 Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
NCT05256745 RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
NCT06005493 Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
NCT06445738 Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
NCT06383026 Individuals on Hormone Therapy Breast Cancer Screening Pilot
NCT05548296 A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
NCT05824975 A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
NCT06400563 MRg-NIRS Imaging System Breast Cancer Trial
NCT06377852 The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
NCT07869355 BRE-13: Mediterranean Diet
NCT06370143 A Study Collecting Health Information to Understand and Prevent Gastric Cancer
NCT05059444 ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT06099093 Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
NCT05975593 MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
NCT06216938 RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
NCT04590326 A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
NCT06488378 Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
NCT05412225 A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
NCT07357298 Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
NCT05042687 Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
NCT06105684 Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
NCT07033026 An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
NCT07287150 A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT06476808 A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
NCT04959474 Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
NCT05679674 Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer
NCT06934538 First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
NCT04589468 Researching the Effect of Exercise on Cancer
NCT06763432 Positive Fit to Colonoscopy: Closing the Gap
NCT07463833 Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
NCT07595874 Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
NCT06824818 Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
NCT07817147 CREO - Microwave Ablation Feasibility Study
NCT07202247 Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
NCT07635147 Decision Support Tool for Patients With Advanced Breast Cancer
NCT07702032 Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
NCT06567314 Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
NCT07360119 Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
NCT04674267 Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT07705334 A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
NCT04469764 Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
NCT04603209 Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
NCT07478016 EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT07781800 Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health
NCT04706663 Precision-Based Genomics in Prostate Cancer
NCT06760819 A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06395519 A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
NCT07755436 Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
NCT06298916 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
NCT07285057 Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
NCT05155033 Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
NCT07276438 Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
NCT06246968 A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
NCT06507618 Pre-Operative Window of ET to Inform RT Decisions (POWER II)
NCT06904378 ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
NCT06636682 FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
NCT05464810 Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
NCT06136624 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
NCT06400550 Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06595160 Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT03250078 A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
NCT06815497 Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
NCT06860815 Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
NCT05313191 Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
NCT03334708 A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT05107674 A Study of NX-1607 in Adults With Advanced Malignancies
NCT06949410 HER2 Vaccine for Locally Advanced Breast Cancer
NCT06545682 Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
NCT04775355 Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer
NCT02526368 Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
NCT06648278 Patient Care Outreach, Navigation, Technology and Support 2.0
NCT07627191 GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
NCT04548817 Neurocutaneous Melanocytosis Registry
NCT05997017 Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
NCT07216560 First-in-human Study of 7MW4911 in GI Cancer
NCT07550517 PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
NCT04697576 Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
NCT04434040 Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
NCT03711890 Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
NCT07221825 Low-Count Quantitative SPECT for Men Treated With Radium-223
NCT07203378 Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
NCT06959550 Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
NCT00588185 [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
NCT07544589 A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
NCT07224750 A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
NCT06131840 A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
NCT06615752 Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
NCT07086833 The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
NCT07106359 Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
NCT04134780 Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
NCT02393703 Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
NCT07271017 Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
NCT07186296 EXoPERT EMERALD Clinical Study
NCT05546827 Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma
NCT07128927 Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors
NCT07223424 Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
NCT06340620 EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
NCT07064018 Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
NCT06974110 Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT04907643 Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NCT07014618 Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
NCT05291507 Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT05321134 Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
NCT06374459 Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
NCT06662786 A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
NCT06923527 Circulating Tumor DNA
NCT07270666 ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NCT07225270 Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
NCT07481383 A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
NCT07043270 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
NCT06555588 Engage Psychosocial Intervention for Cancer Symptoms
NCT06861088 The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
NCT06660420 Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
NCT05660083 Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
NCT07701941 A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
NCT07827573 A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment
NCT05633654 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT07619079 Malignant Polyp Registry
NCT07801664 Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer
NCT06526299 Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
NCT07895498 A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer
NCT06369285 A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
NCT07594106 REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
NCT07225114 Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
NCT03861676 Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
NCT05719558 A Study of ASP1002 in Adults for Treatment of Solid Tumors
NCT07293585 Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
NCT04354064 Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
NCT04022616 Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
NCT03943316 Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer
NCT05125016 A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
NCT07032584 Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
NCT06760507 Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
NCT06295965 Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
NCT07048314 Stem Cells for Erectile Dysfunction Post RALP
NCT07525206 A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
NCT05840484 Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance
NCT07219238 Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
NCT07463599 Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
NCT06342401 Early Onset Colorectal Cancer Detection
NCT04924075 Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
NCT06040541 Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
NCT05051722 Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
NCT04545957 Jump: MR Simulation For Radiation Therapy Master Protocol
NCT07173257 PROMs After Pancreatectomy
NCT04692818 3D Ultrasound Breast Imaging
NCT07231627 AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
NCT06499870 Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
NCT06378866 Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
NCT05478694 Outcomes of Focal Ablation for Prostate Cancer
NCT06864754 WashU DIEP Flap Video and Patient Understanding Improvement
NCT05001477 Customized TULSA-PRO Ablation Registry
NCT05985954 Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
NCT07164456 Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
NCT05379595 A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
NCT07332000 A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
NCT06820463 A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
NCT06392295 PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
NCT05914116 A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
NCT07654257 Single FrAction Interstitial BreaSt BracHytherApy
NCT04214119 EsophaCap for the Detection of Early Esophageal Carcinoma
NCT06138067 Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
NCT00477100 Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
NCT06902311 Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
NCT06330064 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
NCT04521764 A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
NCT07220967 A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
NCT05043012 Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
NCT07828236 Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal Adenocarcinoma
NCT07587229 Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
NCT04191551 The GAstric Precancerous Conditions Study
NCT07220239 Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NCT04861077 Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
NCT07813637 Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
NCT07649057 A Study of a Urine Test to Detect Colorectal Cancer
NCT01834001 Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT05625529 ExoLuminate Study for Early Detection of Pancreatic Cancer
NCT07401381 A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
NCT07262138 Active Surveillance in Older Women With ER+ Breast Cancer
NCT06626516 Tebentafusp-tebn With LDT in Metastatic UM
NCT06203106 NYSCF Scientific Discovery Biobank
NCT06158139 Autologous CAR-T Cells Targeting B7-H3 in PDAC
NCT07148128 Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
NCT07282158 Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
NCT03842943 Neoadjuvant Combination Immunotherapy for Stage III Melanoma
NCT07564141 Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
NCT06040970 Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
NCT05386108 Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
NCT07198074 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
NCT07454603 A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
NCT05692024 COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
NCT06966388 Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
NCT05454488 An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
NCT06545942 Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
NCT06235697 Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
NCT07488923 A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
NCT06411691 KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
NCT05056818 Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
NCT07541079 A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
NCT04765150 Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
NCT07504796 ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
NCT05746182 Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
NCT03396341 Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
NCT06896162 PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
NCT06638294 Study in Patients With Breast Cancer Leptomeningeal Metastasis
NCT07833566 Biopsy-site-marker in Breast Cancer
NCT05620329 UNC Pleural Fluid Registry
NCT06200259 Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
NCT05054296 Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
NCT04222413 Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
NCT06478589 Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
NCT04074720 Prospective Breast Cancer Biospecimen Collection
NCT07040891 A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials
NCT05384535 Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
NCT05150691 A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
NCT07211659 Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
NCT04799535 Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
NCT04588025 Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
NCT06931340 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
NCT06607458 Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
NCT07832617 Protoacoustic Imaging For 3D Mapping
NCT07001748 Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
NCT06610825 Castrate Resistant Prostate Cancer Enhertu Therapy
NCT01638676 A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
NCT06536374 Folate Study in Men With Advanced Prostate Cancer
NCT06946225 ACTengine® IMA203 Combined With mRNA-4203
NCT06981208 ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
NCT07805954 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
NCT06728072 Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
NCT05176483 Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT07335354 A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
NCT07261631 Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
NCT06073431 LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT07283939 Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NCT06165419 Definitive Radiation for High-Risk Spine Metastases
NCT05915442 Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
NCT04970056 Pancreatic Cancer Early Detection Consortium
NCT05316129 Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
NCT07407920 Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
NCT04683679 A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
NCT06176261 DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
NCT05006131 Pancreatic Cancer Screening for At-risk Individuals
NCT05890677 The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NCT07201519 Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
NCT05812807 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
NCT07875192 Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting
NCT06666790 DermaSensor Postmarket Surveillance Study
NCT05654246 Susan G. Komen's ShareForCures
NCT06067269 Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
NCT07205822 A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
NCT05758688 PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
NCT06030622 Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer
NCT05245812 Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy
NCT07768436 A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
NCT05462496 Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
NCT06264180 VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
NCT05803382 Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
NCT07824583 A Study Evaluating a New Radiation Treatment Workflow (NGDS)
NCT06953245 Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
NCT06666439 Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
NCT06058377 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
NCT07690579 Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
NCT06635980 Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
NCT07069712 A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
NCT07685249 Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
NCT07748208 A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
NCT05428735 The DRAGON 2 Trial
NCT07189403 A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
NCT04945642 High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
NCT07237269 Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
NCT07148245 Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
NCT07545811 Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
NCT07403981 Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
NCT05989828 A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
NCT05765500 RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
NCT07029490 Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
NCT04586959 Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
NCT07643012 Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
NCT03556228 VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
NCT07348367 A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
NCT06366490 Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
NCT06807359 Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
NCT07224724 Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
NCT06907446 Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies
NCT07389239 A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
NCT07535112 A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
NCT07779967 Alcohol, Breast Cancer, and Metabolism
NCT06139107 RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
NCT07227168 A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
NCT07468903 Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
NCT05687123 Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
NCT03785288 Vaginal Cuff Brachytherapy Fractionation Study
NCT07554560 Nutrition Intervention for Pancreatic Cancer
NCT05136196 BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
NCT06541210 Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
NCT06353997 Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
NCT05384496 Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
NCT07109817 Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer
NCT05935384 SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
NCT06260033 Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
NCT06414733 HER-2 B Cell Peptide Vaccine
NCT07427043 Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)
NCT06401889 Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
NCT03492671 Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
NCT06562192 Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT07690917 A Study of a New PET Scanner in People With Cancer
NCT04700332 PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
NCT03054584 Genetic Basis of Melanocytic Nevi
NCT07478185 Prehab for Pancreatic Cancer Surgery
NCT04751435 Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
NCT04778449 Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
NCT05696626 Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
NCT07223047 A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
NCT04048278 Lidocaine Infusion in Pancreatic Cancer
NCT07509008 Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
NCT06580314 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
NCT06780176 A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
NCT07830225 A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.
NCT07361614 Pilot Testing of a Colorectal Cancer Education Program
NCT06887205 Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
NCT07184970 PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
NCT06626022 Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
NCT07278986 CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
NCT05000294 Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
NCT04360330 SABER Study for Selected Early Stage Breast Cancer
NCT03606967 Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
NCT07227636 A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
NCT06128551 Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT02610439 Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
NCT06806930 Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
NCT06070012 Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
NCT07553234 Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment
NCT07647328 A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
NCT06044857 PSMA PET Response Guided SabR in High Risk Pca
NCT06072612 Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
NCT05873192 Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
NCT07136181 Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
NCT07631000 A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
NCT06757192 CRC Screening in Unscreened Individuals 45-54
NCT07386444 Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
NCT07675967 Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
NCT02478892 Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
NCT04523857 ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
NCT07120100 Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
NCT07144228 Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
NCT04513028 Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
NCT04606030 LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
NCT00353483 Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
NCT06481592 A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
NCT07578571 A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
NCT07778498 A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
NCT06168487 Telmisartan in Prostate Cancer
NCT06785636 A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
NCT06648434 MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
NCT07020221 A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
NCT04221893 Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NCT01900821 National Mammography Database
NCT05854498 Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
NCT05208762 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
NCT07551596 Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
NCT06559059 Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
NCT07578649 Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
NCT06314958 Stage II/III Colorectal Cancer Recurrence
NCT07215000 Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
NCT07513311 A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
NCT07125209 Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers
NCT07136428 Asciminib in HER2+ Breast Cancer Brain Metastases
NCT05636111 Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
NCT05366881 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT07137871 Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
NCT06801236 Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06888388 Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
NCT04410302 Patient-Derived Xenografts to Reduce Cancer Health Disparities
NCT05398302 Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
NCT05013255 Pioglitazone Therapy Targeting Fatigue in Breast Cancer
NCT04373564 Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
NCT04526587 Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
NCT06922318 The COSMYC Trial (COmbined Suppression of MYC)
NCT07254910 Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
NCT06957691 Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
NCT05123482 A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
NCT07224425 A Study of BI 3810944 in Patients With Advanced Cancer
NCT06040125 Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
NCT06708429 Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
NCT06802172 Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
NCT05020574 Microbiome and Association With Implant Infections
NCT04339374 Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
NCT03784924 EDRN Prostate MRI Biomarker Study
NCT05863195 Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
NCT05998135 Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
NCT06413680 A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
NCT04150042 SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT05627960 First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
NCT05447923 Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
NCT05274048 Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
NCT07318389 ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
NCT06451497 This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
NCT07361562 A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
NCT07225946 A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT05483283 Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
NCT04167969 The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
NCT06605430 Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
NCT06940271 Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy
NCT04794322 Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
NCT07417488 GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
NCT07823322 A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy
NCT05764720 Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
NCT06826924 7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
NCT05092373 Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
NCT07127003 ILR to Prevent BRCL_MCC 23608
NCT07634380 Sitagliptin With Pembro in RCC and Melanoma
NCT05630794 Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
NCT07426913 Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
NCT03692429 alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
NCT07652242 Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
NCT06727773 Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
NCT06745895 Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
NCT06989437 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
NCT07677839 UHFUS Characterization of Normal Lymphatic Anatomy
NCT03161522 Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
NCT05349227 Comprehensive Outcomes for After Cancer Health
NCT01102556 PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
NCT03492151 Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
NCT05491226 Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
NCT06998940 Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
NCT04913285 A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT07327489 Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
NCT07645391 Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
NCT07890415 Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
NCT07434817 Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment
NCT04475640 Cancer Genetic Testing in Ethnic Populations
NCT05503797 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
NCT06956690 A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
NCT06915025 Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
NCT07405476 Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
NCT05879926 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT03259867 Combination of TATE and PD-1 Inhibitor in Liver Cancer
NCT07213609 A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
NCT03354416 Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
NCT05877599 A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
NCT07296887 CARE Tool Study Aim 3
NCT05280314 Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
NCT05983432 Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
NCT04918186 Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
NCT05422794 Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
NCT06984562 Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
NCT06052488 Strength After Breast Cancer
NCT06179303 Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
NCT07044583 SAVE Trial: SAfe Opioid Use Video Education
NCT07804186 Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
NCT06800105 Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
NCT00040352 Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
NCT04370587 A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
NCT05720338 Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
NCT03823144 Intravital Microscopy in Human Solid Tumors
NCT06425926 Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
NCT01954992 Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
NCT06141993 ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
NCT06225011 Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
NCT07487844 Pulsed Electric Field Ablation for Metastatic Breast Cancer
NCT07213804 A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
NCT07504835 GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
NCT02775643 Molecular Analysis of Childhood and Adolescent Melanocytic Lesions
NCT07930182 Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring
NCT05373823 MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
NCT06937996 Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
NCT07553390 Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers
NCT04636710 Refining Local-Regional Therapy for IBC
NCT06441890 BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
NCT07612215 Elacestrant in Advanced Triple Positive Breast Cancer
NCT06548789 Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
NCT07505797 ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
NCT07818018 A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
NCT05187182 CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
NCT06518746 Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
NCT05287451 Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT06194929 Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
NCT05770531 Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
NCT07550088 BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
NCT07166042 Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
NCT06807437 Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
NCT03990896 Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
NCT07286331 A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
NCT04406831 The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
NCT04701645 Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
NCT06750094 A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
NCT06543537 Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
NCT06362369 A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
NCT05774951 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
NCT07546331 Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
NCT06066437 NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
NCT07199764 Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
NCT05919264 FOG-001 in Locally Advanced or Metastatic Solid Tumors
NCT07162337 BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
NCT06663319 A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
NCT07476001 Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
NCT05315700 Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
NCT02328677 ColoCare Study - Colorectal Cancer Cohort
NCT02870244 Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
NCT07619534 Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
NCT05929768 Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT06276491 Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
NCT05239546 Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
NCT05625659 Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NCT06503146 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
NCT07288359 Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
NCT07555210 Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
NCT07776613 A Study of Romosozumab in People With Breast Cancer and Osteoporosis
NCT01766297 Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
NCT07751159 Radiation Therapy Approaches for People With Prostate Cancer
NCT04946370 Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
NCT06388122 DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
NCT06997029 A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
NCT06085313 Cancer Pain Management Using a Web-based Intervention
NCT04751396 Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
NCT07181473 A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
NCT05652686 A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
NCT05803941 Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
NCT06295159 Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
NCT05304962 FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
NCT07450859 A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05864196 Two Fraction Prostate SBRT With DIL SIB
NCT06504147 A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
NCT06855706 An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study
NCT07500298 Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
NCT06999798 An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
NCT06205849 Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
NCT05052671 ctDNA Assay in Patients With Resectable Pancreatic Cancer
NCT06434064 Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
NCT04516447 A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
NCT07059884 Distance-Based Exercise to Preserve Function and Prevent Disability
NCT06293898 Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
NCT06856694 RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
NCT03451383 Older Breast Cancer Patients: Risk for Cognitive Decline
NCT05629494 Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
NCT04994067 Intra-Operative Radiation Registry
NCT06084416 A Study of Sovilnesib in Subjects With Ovarian Cancer
NCT06257693 Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
NCT07912593 A KRAS Inhibitor in Participants With Advanced Solid Tumors
NCT07770100 Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
NCT05295407 Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT07739563 EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
NCT07621614 A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
NCT06568016 A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
NCT05902507 Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
NCT03448926 The PREDICT Registry:
NCT04074135 Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
NCT05074290 Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients
NCT07345676 Colorectal Cancer Screening Outreach
NCT07832292 A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
NCT07107334 A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
NCT06582615 Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
NCT05593497 A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
NCT05984589 Personalized Health Self-Management Training for Colorectal Cancer Survivors
NCT07224789 Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
NCT07379138 Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
NCT05505643 Cryoablation vs Lumpectomy in T1 Breast Cancers
NCT07851025 Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer
NCT04567771 Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
NCT06876714 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
NCT04844528 Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
NCT04305834 Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
NCT07217704 Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
NCT06605404 Pan-tumor MRD Study
NCT07126158 Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
NCT07216248 Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer
NCT05780684 Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
NCT05242744 FTT PET/CT in Metastatic Prostate Cancer
NCT07050771 Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
NCT02997293 Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery
NCT06195306 Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT07284849 A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT05789433 Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
NCT05592626 A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
NCT06161506 Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
NCT07455058 Water Vapor Ablation for Prostate Cancer: Long-Term Registry
NCT05379985 Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
NCT07066189 Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
NCT06112314 IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT07529808 Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
NCT06364410 Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
NCT06674863 Addressing Health Literacy With a Tailored Survivorship Care Plan
NCT06683755 Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
NCT03322891 Improving Health Literacy in African-American Prostate Cancer Patients
NCT05805436 Preop Laxatives in Robotic Urologic Surgery
NCT05142800 Screening For BCRL In Targeted Therapy For Breast Cancer
NCT07278336 A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
NCT07416552 A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
NCT04348747 Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
NCT04472338 Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
NCT07814248 A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
NCT06401421 EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
NCT06888102 A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
NCT07383649 Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
NCT06405828 Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
NCT07644598 MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
NCT05323409 Improving Comprehensive Care of Cancer Patients
NCT06423963 Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
NCT07406087 Navigation Intervention for Adolescent and Young Adult Cancer Survivors
NCT04677816 Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
NCT06067841 A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
NCT07124611 A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer
NCT06460298 ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
NCT07069556 ColoSense Post-Approval Study
NCT05952453 Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
NCT04557969 Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
NCT06785441 Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
NCT07227831 A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
NCT03151629 International Registry for Men With Advanced Prostate Cancer (IRONMAN)
NCT03933670 Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
NCT06262139 Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
NCT03608631 iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
NCT06789653 A Novel Approach Utilizing Organ Specific Age Proteomics
NCT07059845 A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
NCT07553572 Remote Monitoring and Symptom Management Digital Application
NCT05490472 JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
NCT03769766 Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
NCT05496829 IMPACT Trial: Intervention to iMProve AdherenCe Equitably
NCT06369246 PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.
NCT06654037 Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
NCT07612046 A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
NCT06738303 Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
NCT07235293 A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
NCT05519449 Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
NCT02422641 Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
NCT07142551 Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
NCT05130801 A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
NCT05026983 Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
NCT06236139 Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07206121 Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
NCT06450106 Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
NCT07460752 Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
NCT07071038 Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
NCT04473794 Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
NCT07543757 Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
NCT06423326 Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
NCT02620852 Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NCT06948448 A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
NCT07730021 A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
NCT06730347 A Study of Lorigerlimab in Participants With Advanced Solid Tumors
NCT07213791 A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
NCT07746713 A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
NCT06903468 Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
NCT06515613 A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
NCT04489238 Collection of Information to Better Understand Young Onset Colorectal Cancer
NCT07906717 A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer
NCT06864338 Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
NCT05592938 Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT06833255 A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
NCT03769415 Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
NCT07624617 Fast-Her: Fasting Effects on Breast Cancer Treatment
NCT07444606 Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
NCT05501704 ETHAN - ET for Male BC
NCT06288113 Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
NCT07618273 Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial
NCT07572162 Post-market Safety Study of LUMISIGHT
NCT06887218 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
NCT05568550 Pembro With Radiation With or Without Olaparib
NCT07215988 Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
NCT07527143 Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
NCT07593079 Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
NCT07281924 Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
NCT05142033 Avera Cancer Sequencing and Analytics Protocol (ASAP)
NCT05269381 Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
NCT07228000 Bundled Cancer Screening and Genetic Services Navigation
NCT06723236 A Study of MGC028 in Participants With Advanced Solid Tumors
NCT06305299 Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
NCT06581406 A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
NCT05245500 Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
NCT06830265 Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis
NCT03833921 Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
NCT07444814 Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
NCT07622901 Fasting InTervention for Endometrial Cancer
NCT05607095 A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
NCT07500012 taVNS for Breast Cancer Pain and Symptom Management
NCT06084481 Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
NCT06172283 Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NCT07189195 TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
NCT07332975 ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
NCT07173751 ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
NCT07102381 A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
NCT06731894 Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
NCT03538665 The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
NCT04857502 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
NCT05677802 Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
NCT06855654 Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
NCT06171139 Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
NCT07764796 Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya
NCT05804370 Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
NCT06789172 A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06705686 Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
NCT05926102 The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
NCT07006727 Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
NCT07765927 Exercise Oncology Clinic Pilot Feasibility Trial
NCT07322094 CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
NCT05649072 Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
NCT05795101 TRUDI: TDXD+Durva in HER2+/Low IBC
NCT05896839 Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
NCT07405801 A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
NCT06496256 Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
NCT07226427 A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
NCT06774027 Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
NCT07018986 The MIND-BC Study: MIND Diet for Breast Cancer Cognition
NCT06217822 First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT04429542 Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
NCT04616131 Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy
NCT07294703 Factors Associated With Breast Cancer Risks and Outcomes
NCT06022029 A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
NCT07909031 CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT06636123 GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
NCT07109427 Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
NCT05974150 Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
NCT05464082 Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
NCT07226713 Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
NCT07487168 Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
NCT03877796 Clinical Pre-screening Protocol for Ovarian Cancer
NCT03564340 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
NCT05659797 FES BPET-DBT in Newly Diagnosed Breast Cancer
NCT01042379 I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
NCT06318897 Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
NCT06710288 A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
NCT07677254 A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07455903 Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
NCT05005403 Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
NCT07303894 A Study of Isoquercetin in People With Ovarian Cancer
NCT07725172 Radiation Therapy and Thymus Function in Young Women With Breast Cancer
NCT07535541 A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
NCT04329494 PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
NCT06963905 Saci Nivo Rela for TNBC
NCT07179809 Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
NCT04489719 Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
NCT04995198 PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
NCT06932757 Adjuvant Quisinostat in High-Risk Uveal Melanoma
NCT06666192 The Ohio State University (OSU) SCREEN Community Program
NCT04230109 Sacituzumab Govitecan In TNBC
NCT06111781 The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
NCT05366699 LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
NCT06591819 Hypofractionated WPPT With HDR Boost
NCT07114601 A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT06063928 Confronting Cancer as a Community
NCT06336928 A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
NCT03723928 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NCT06251544 TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
NCT06638307 A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
NCT05588128 Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
NCT07158164 DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
NCT06934239 A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
NCT05187832 A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
NCT03449238 Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
NCT05830058 Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
NCT05766371 Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
NCT07227233 Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
NCT05819892 Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
NCT07165132 Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
NCT06483048 MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
NCT06731998 Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
NCT07685938 Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
NCT04052048 Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
NCT07543055 A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
NCT06120283 BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT07216495 Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC
NCT07646847 A Study of a Side Effects and Resource Navigation Program for People With Cancer
NCT07060807 A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT06105749 Biennial CEM in Women With a Personal History of Breast Cancer
NCT06799065 First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
NCT07124000 DESTINY-PANTUMOUR04
NCT06565052 The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
NCT06898333 Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
NCT04678648 A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies